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Abstract
Background: Deriving valid variant calling results from raw next-generation sequencing data is a particularly
challenging task, especially with respect to clinical diagnostics and personalized medicine. However, when using
classic variant calling software, the user usually obtains nothing more than a list of variants that pass the
corresponding caller’s internal filters. Any expected mutations (e.g. hotspot mutations), that have not been called by
the software, need to be investigated manually.
Results: BBCAnalyzer (Bases By CIGAR Analyzer) provides a novel visual approach to facilitate this step of time-
consuming, manual inspection of common mutation sites. BBCAnalyzer is able to visualize base counts at predefined
positions or regions in any sequence alignment data that are available as BAM files. Thereby, the tool provides a
straightforward solution for evaluating any list of expected mutations like hotspot mutations, or even whole regions
of interest. In addition to an ordinary textual report, BBCAnalyzer reports highly customizable plots. Information on the
counted number of bases, the reference bases, known mutations or polymorphisms, called mutations and base
qualities is summarized in a single plot. By uniting this information in a graphical way, the user may easily decide on a
variant being present or not – completely independent of any internal filters or frequency thresholds.
Conclusions: BBCAnalyzer provides a unique, novel approach to facilitate variant calling where classical tools
frequently fail to call. The R package is freely available at http://bioconductor.org. The local web application is available
at Additional file 2. A documentation of the R package (Additional file 1) as well as the web application (Additional
file 2) with detailed descriptions, examples of all input- and output elements, exemplary code as well as exemplary
data are included. A video demonstrates the exemplary usage of the local web application (Additional file 3).
Keywords: Variant calling, Next-generation sequencing, Visualization, Personalized medicine, Hotspot mutations
Background
Personalized medicine is striving to find its way into clin-
ical routine. Some therapeutic decisions are already influ-
enced by the presence or absence of certain mutations.
Sequencing in such contexts is usually performed using
next-generation sequencing (NGS). However, the analysis
of NGS data may be complicated by a number of reasons.
On the one hand, false positive calls due to artifacts in the
sequencing data may harm the results. On the other hand,
false negative calls due to low variant allele frequencies or
bad coverage of certain regions can lead to true mutations
not being detected.
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There are many of programs in terms of variant calling,
like GATK [1] or SAMtools [2]. However, – apart from
some user-definable thresholds – these programs are usu-
ally a black box. They take a BAM file as input, apply a
number of partially complex filtration steps and return a
VCF file containing a list of likely variants. Variants with
low allelic frequencies – even if they are known hotspot
mutations – are usually excluded to keep the number of
false positive calls low. Even recently developed sophisti-
cated approaches like MutAid [3] that provide a complete
data analysis pipeline for Sanger- and next-generation
sequencing data, including different mapping and variant
calling algorithms, finally report a VCF file per sample and
a variant summary table. Furthermore, tools developed
for NGS analysis in a clinical setting, e.g. CSN and CAVA
[4], usually focus on the correct annotation of previously
called variants.
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To our knowledge, there are no freely available variant
calling tool that can use as input a list of likely muta-
tions that should be considered with an especially low
allelic frequency. Neither is it possible to perform a com-
parable analysis of positions where no variant is called,
but the user is interested in the raw number of bases.
As a consequence, a manual, time-consuming inspec-
tion of all sites where mutations are expected but not
called is necessary.
The integrative genomics viewer (IGV) [5] provides
such an option for the manual investigation of the dif-
ferent number of bases, deletions and insertions at any
position in the genome. However, it is time consuming to
load different samples into the program and to look at the
different positions of interest. Moreover, there is no way of
automatically summing up and visualizing the base counts
for a list of positions in IGV. Other tools, like the R pack-
ages Rsamtools [6] and VariantTools [7], provide options
for counting the number of bases and determining qual-
ity summaries at a selected set of positions. However, as
the output is textual, programming one’s own solution for
visualization is necessary. Altogether, this does not appear
to be a satisfactory solution for clinical routine.
In the use case of medical diagnostics, a tool perform-
ing detailed analyses of those locations where mutations
are expected – but not always called – may prove to be
very useful. Low allelic frequency and bad base quality
may often explain why calls are missed. However, in case
of missing calls this information is not included in a VCF
file and is difficult to obtain from IGV.
To facilitate the analysis of called and uncalled muta-
tions, we developed BBCAnalyzer (Bases By CIGAR
Analyzer). Just like common variant callers, the applica-
tion uses a BAM file as input. It analyzes the CIGAR
strings that characterize themapped reads and reports the
number of bases, deletions and insertions at any prede-
fined position or region in comparison to any reference
genome in a novel visual- and a common textual way.
The analysis as well as the plots may be customized
in a number of ways.
Implementation
BBCAnalyzer is implemented in R and available at http://
bioconductor.org. Additionally, a web application for
BBCAnalyzer is available at Additional file 2. The tool
works with any sequence alignment data that are available
as BAM files.
Input
In addition to the BAM files to be analyzed, BBCAnalyzer
needs the corresponding BAI files. When using BBCAna-
lyzer as a classical R package, a file summing up the sample
names and a target file containing the positions or regions
to be analyzed have to be provided. When using BBCAna-
lyzer as a web application, the sample names and the target
regions to be analyzed have to be provided in an input
field. Optionally, a VCF file containing known mutations
or polymorphisms and VCF files for each sample resulting
from earlier performed variant calling may be provided.
Preparation of the plotting
Prior to the actual plotting, BBCAnalyzer performs vari-
ous steps of preparation.
First, an analysis of the target region is performed. BBC-
Analyzer is able to deal with target regions as well as single
target bases.
Next, detected bases, deletions and insertions at every
defined position are written out by analyzing available
CIGAR strings. Furthermore, the quality for every base
(also insertions) is written out. A threshold for excluding
reads with bad mapping quality may be defined. BBCAn-
alyzer equally copes with uncovered positions as well as
insertions >1 bp.
Subsequently, the number of detected bases, deletions
and insertions at every position is summed up. Addition-
ally, mean quality of detected bases – including insertions
and for the inserted bases only – is calculated. A threshold
may be set to exclude bases with bad quality. The num-
ber of excluded bases is counted and reported separately.
In case of VCF files being available for every sample, the
expected number of bases, deletions and insertions are
determined based on the called alternate alleles and the
assigned genotypes.
Finally, the ratios of the detected bases, deletions and
insertions (additionally) are determined. Based on the
ratios, up to six different calls are reported. A threshold
may be set to ignore variants with a minor ratio. In the
case of an available VCF file containing the called vari-
ants for every sample, the call – taking into account the
reference allele, the alternate alleles and the genotype – is
determined.
Plotting
The essential feature of BBCAnalyzer is its plotting func-
tionality. On the basis of the determined base counts, bar
plots are generated. The user can choose between one bar
plot per sample, focusing the analysis on various target
bases at a time, or one bar plot per position, setting the
focus of the analysis on the direct comparison of many
BAM files at a single position. In addition, the absolute or
relative number of counts can be plotted (see Fig. 1).
In each case, the previously determined numbers of
detected bases, deletions and insertions are plotted on the
positive y axis of the bar plot. The bars are colored accord-
ing to the base (adenine: green; cytosine: blue; guanine:
yellow; thymine: red; deletion: black; insertion: color of
the inserted base or bases plus purple edge). If the mean
quality of the bases is considered, a lower and an upper
Sandmann et al. BMC Bioinformatics  (2017) 18:133 Page 3 of 6
Fig. 1 Exemplary output file from real patient data generated by Illumina NextSeq. Relative number of reads at seven positions analyzed in case of
sample “Example_Illumina”. Reference bases are plotted at the negative y axis, detected bases in the mapped reads are plotted at the positive y axis
(marked 5% threshold). Likely SNV at chr1:115,258,747 (reference C, ∼70% of the reads with high-quality C and ∼30% of the reads with high-quality
T). No variant at chr2:25,467,204 (reference G, ∼100% of the reads with high-quality G). Unlikely SNV at chr2:198,267,280 (reference C, ∼95% of the
reads with low-quality C, ∼5% of the reads with low-quality A). Likely deletion at chr4:106,157,106 (reference A, ∼75% of the reads with high quality
A, ∼25% of the reads with deleted A). Known homozygous SNP at chr17:7,579,472 (reference G, polymorphism C displayed as additional reference
base, ∼100% of the reads with high-quality C). Possible insertion of a “G”, but unlikely deletion at chr20:31,022,442 (reference G, ∼97% of the reads
with high-quality G, ∼3% of the reads with deleted G, ∼30% of the reads with inserted high-quality G). Likely SNV at chr21:44,514,777 (reference T,
∼65% of the reads with high-quality T, ∼35% of the reads with high-quality G)
boundary may be set. A high mean quality close to the
upper bound leads to a darker coloring of the bar.
In addition to the counted bases, the reference bases
(hg19 in Fig. 1) at the targeted positions are plotted on
the negative y axis. In doing so, single nucleotide variants
(SNVs) may directly be identified (Fig. 1, chr1:115,258,747
or chr21:44,514,777 in comparison to chr2:198,267,280).
If a VCF file containing known variants, e.g. originat-
ing from dbSNP [8], is given, additional reference bases
are included in the plots at the corresponding positions
(Fig. 1, chr17:7,579,472).
BBCAnalyzer is able to visualize insertions of 1 bp
(Fig. 1, chr20:31,022,442), but also long insertions of >
1 bp by repeatedly analyzing the same position. This is
even possible, when many samples are analyzed in paral-
lel, but the corresponding position is not covered in all
cases. Furthermore, BBCAnalyzer is able to cope with dif-
ferent inserted bases at the same position by plotting them
as stacked bars.
An exemplary visualization of a deletion is displayed at
position chr4:106,157,106 in Fig. 1.
If VCF files for all samples are provided, the expected
number of bases, deletions and insertions on the basis of
the assigned genotype are added to the bar plots using
dashed lines.
To account for the ratio of detected bases, deletions and
insertions – even if their absolute numbers are chosen to
be plotted –, a vector may be defined giving the ratios at
which horizontal lines shall be drawn in the plots, e.g. 25,
50 and 75%. However, this function may also be used to
mark a variant calling threshold at e.g. 5% (Fig. 1).
Output
The bases and their qualities at every analyzed position,
the absolute number of counts and the relative frequen-
cies together with the corresponding calls get reported as
separate TXT files.
When using BBCAnalyzer as an R package, the user can
provide an output directory for the plots. If he does, all
plots generated by BBCAnalyzer get automatically saved
as PNG files. Otherwise, the plots are returned to the
workspace.
When using BBCAnalyzer as a web application, all plots
generated by BBCAnalyzer get automatically saved as
PNG files in the given output directory. Additionally, all
plots get displayed in the application’s output panel.
Results and discussion
The performance of every variant calling tool is influ-
enced by numerous parameters. General characteristics of
the data, e.g. average coverage or the level of sequencing
errors, can prevent a true mutation from being called, but
variant-specific characteristics, e.g. the variant allele fre-
quency or the surrounding basesmay also influencemuta-
tion calling. Calling mutations in repetitive regions as well
as low-frequency mutations is especially challenging.
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With the help of two exemplary cases of real sequencing
data (Illumina NextSeq) from patients with myelodysplas-
tic syndrome (MDS), we show how BBCAnalyzer is able
to facilitate variant calling where common variant calling
tools frequently fail.
Using BBCAnalyzer to detect mutations in repetitive
regions
Depending on the repeated motive, calling mutations in
repetitive regions can be very challenging. As an example,
we consider the insertion of G in case of a homopolymeric
stretch of eight Gs (chr20:31022442;insG). This mutation
in ASXL1 is regarded as a hotspot mutation for MDS and
other myeloid malignancies.
We perform variant calling with two standard tools:
GATK and SAMtools. Five sets of sequencing data are
analyzed (UPN1-UPN5). Only in case of UPN1 the
expected mutation on ASXL1 is called. Furthermore, the
mutation is only called byGATK, not by SAMtools. GATK
reports a depth ofDP = 188. 142 reads containing the ref-
erence allele and 43 reads containing the alternate allele
are reported. Thus, the allelic frequency is VAF = 0.23.
The presence of the mutation in UPN1 was confirmed by
Sanger sequencing [9].
In addition to classical variant calling, we use BBCAna-
lyzer to analyze position chr20:31,022,442. The results are
displayed in Fig. 2. The following options were defined:
no vcf input for every sample, no file containing known
mutations, reference genome hg19,MQ threshold=60, BQ
threshold=50 (ASCII coded; corresponds to Phred qual-
ity score of 17), frequency threshold=0.01, quality lower
bound=58 (ASCII coded; corresponds to Phred quality
score of 25), quality upper bound=63 (ASCII coded; cor-
responds to Phred quality score of 30), mark at 20%, plot
relative number of bases, return one plot per analyzed
position.
The analysis of position chr20:31,022,442 with BBCAn-
alyzer underlines our previous findings in case of sample
UPN1. More than 20% of the reads feature an inserted
G. However, the frequencies determined by BBCAnalyzer
differ considerable from the ones reported by GATK. 4855
reads contain the reference allele, 10 reads contain an A,
159 a deletion, 1394 an insertion and 56 are excluded due
to low base quality. Obviously, GATK applies a number of
filters by default that exclude a majority of calls.
Considering the remaining sequencing data, it becomes
obvious that samples UPN2, UPN3 and UPN5 feature no
significant difference between the number of reads con-
taining a deletion and the number of reads containing an
insertion. It is thus likely, that these samples do not have
a true mutation at the analyzed position. Sanger sequenc-
ing also indicated that the mutation was not present in
these samples. Sample UPN4 however shows results that
are very similar compared to UPN1. 12,355 reads con-
tain the reference allele, 21 reads contain an A, 2 reads
contain a C, 1 read contains a T, 370 reads contain a dele-
tion, 4051 reads contain an insertion and 183 reads are
excluded due to low base quality. Thus, the allelic fre-
quency of the insertion is VAF = 0.32. Again we perform
Sanger sequencing and indeed the presence of the muta-
tion was confirmed, although it has neither been called by
GATK, nor by SAMtools.
Using BBCAnalyzer to detect low-frequency mutations
Detecting low-frequency mutations in NGS data is, even
if data features a low level of sequencing errors, very chal-
lenging. Some mutations, like chr1:115,258,744;C>A on
NRAS, are important hotspot mutations that occur in var-
ious types of cancer at various VAFs. NRAS mutations
may occur at low frequency and seem to be associated
with transformation to more aggressive disease. There-
fore, it may be relevant to detect these mutations already
at a subclonal level. For a common variant calling tool, like
GATK or SAMtools, it is practically impossible to detect
such a variant.
Based on the real Illumina NextSeq sequencing data we
simulate five sets of sequencing data using ART_Illumina
2.5.8 [10]. To account for specific sequencing errors, we
determine a read quality profile on the basis of the real
Illumina data and use it for the subsequent simulation.
Fig. 2 Analysis of position chr20:31,022,442 with BBCAnalyzer. Relative number of reads (one bar plot per position; marked 20% threshold): UPN1 and
UPN4 feature an inserted G in almost 30% of the reads, while samples UPN2, UPN3 and UPN5 feature no significant difference between the number
of reads containing a deletion and the number of reads containing an insertion. Thus, only samples UPN1 and UPN4 are likely to feature the
mutation chr20:31,022,441 A>AG
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Average coverage of the simulated samples corresponds to
average coverage of the real samples (4034x). Using bam
surgeon [11] we simulate the hotspot mutation in NRAS
in case of three out of five samples with an expected allelic
frequency of VAF = 0.03.
We perform variant calling on our simulated samples
using GATK and SAMtools. However, both tools are
unable to detect the mutation we simulated in any of the
three samples. In addition to classical variant calling, we
again perform analysis of position chr1:115,258,744 using
BBCAnalyzer. The results of the simulated samples are
displayed in Fig. 3A. The following options were defined:
no vcf input for every sample, no file containing known
mutations, reference genome hg19,MQ threshold=60, BQ
threshold=50 (ASCII coded; corresponds to Phred qual-
ity score of 17), frequency threshold=0.01, quality lower
bound=58 (ASCII coded; corresponds to Phred quality
score of 25), quality upper bound=63 (ASCII coded; cor-
responds to Phred quality score of 30), mark at 3%, plot
relative number of bases, return one plot per analyzed
position.
The plot shows that the hotspot mutation on NRAS
is clearly visible in case of SIM1, SIM2 and SIM3. The
observed frequency matches our expectations. Further-
more, it can be observed that the base quality of both,
reads featuring the reference- and reads featuring the
alternate allele, is high.
Just like in case of the simulated data, we analyze five
sets of real Illumina NextSeq sequencing data. Again,
GATK and SAMtools do not report a mutation at
chr1:115,258,744 in case of any of the analyzed samples.
However, when using BBCAnalyze, the mutation is visible
in case of UPN1 (see Fig. 3B). The allelic frequency is
VAF = 0.02. Altogether, BBCAnalyzer detects 10,048
reads containing the reference allele, 247 reads containing
an A, 12 reads containing a T, 14 reads containing a dele-
tion and 231 reads being excluded due to low base quality.
However, similar to the simulated data, reads featuring the
reference- and reads featuring the alternate allele have a
high base quality. It thus appears likely, that sample UPN1
actually contains the NRAS mutation.
As there is no way of validating mutations at such
a low allelic frequency using Sanger sequencing, we
sequenced the sample a second time on Illumina NextSeq
(completely separate experiment with target enrichment,
library preparation and sequencing). The same muta-
tion can be observed with a similar frequency. Therefore,
we assume that sample UPN1 actually features the low-
frequency hotspot mutation in NRAS, although GATK
and SAMtools both fail to call it.
Conclusions
Different from common variant calling tools, we present
an application that provides a novel, visual approach to
facilitate variant calling. Information on the counted num-
ber of bases, the reference bases, known mutations or
polymorphisms, called mutations and base qualities is
united in a novel graphical way. Thereby, BBCAnalyzer
provides a solution for otherwise time-consuming, man-
ual inspection of sites where mutations are expected but
not called. Considering examples of mutations in repeti-
tive regions and low-frequency mutations, we have shown
howBBCAnalyzer can facilitate variant calling where clas-
sical tools frequently fail. Additionally, BBCAnalyzer is
Fig. 3 Analysis of position chr1:115,258,744 with BBCAnalyzer. Relative number of reads (one bar plot per position; marked 3% threshold): a:
Simulated data. A low-frequency mutation (C>A) can be observed in case of samples SIM1, SIM2 and SIM3, but not in samples SIM4 and SIM5. b:
Real data. Similar to the simulated data, the same low-frequency mutation can be observed in case of sample UPN1, but not in samples UPN2-UPN5.
Thus, samples UPN1 is likely to feature the mutation chr1:115,258,744 C>A
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not only available as a classical R package, but also in form
of an intuitively usable web application. This enables a
potentially wide usage of our tool – not only by bioinfor-
maticians, but also biologists and clinicians.
Additional files
Additional file 1: Supplement_1. Detailed documentation of the R
package “BBCAnalyzer”. (PDF 377 kb)
Additional file 2: Supplement_2. Scripts and documentation of the web
application “BBCAnalyzer”. (ZIP 709 kb)
Additional file 3: Supplement_3. Video demonstrating the exemplary
usage of the web application “BBCAnalyzer”. (MP4 11571 kb)
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